Podcasts about diagnostic

HubSpot lost roughly 75% of its blog traffic to AI search—and grew revenue 19% anyway. Everyone wrote the obituary for content marketing, but the traffic that died was the content HubSpot never had the right to own, and everything built on real authority held. In Episode 4 of the PESO Model® Diagnostic, I break down what survived, what didn't, and how to tell which of your own content is an asset versus exposure—before AI makes the call for you. Take your own PESO Model® Diagnostic: https://spinsucks.com/self-peso-diagnostic/ PESO Model® Certification: https://spinsucks.com/peso-model-certification/ Full article: https://spinsucks.com/communication/peso-model-diagnostic-hubspot

The average person with NTOS will not get a correct diagnosis for 4-5 years. They will likely see about 6 specialist MDs looking for a solution and some relief. Some will have unnecessary spinal fusion or cardiac procedures or be on pharmaceuticals for years that don't help.  Here's what we need to do to help.   Online Courses: https://richardhazel.podia.com IG: @richhazel  

Le TDAH en 10 questions clés avec le psychiatre Pr Nader Perroud. Pourquoi tant de femmes découvrent-elles leur TDAH seulement à l'âge adulte, parfois après 40 ou 50 ans ? Quel rôle jouent les hormones dans l'attention, les émotions et l'organisation du quotidien ? Le cycle menstruel, le post-partum ou la ménopause peuvent-ils faire basculer l'équilibre du TDAH ? Comment mieux comprendre ces bouleversements pour retrouver un équilibre ? Hormones, dopamine, diagnostic tardif, traitements et nouvelles pistes de recherche : le Pr Nader Perroud nous aide à comprendre pourquoi tant de femmes sont passées sous les radars du diagnostic et ce que les neurosciences sont en train de mettre en lumière.Bienvenue dans la série de ROUTINES & RITUELS : le TDAH en 10 questions clés avec le Pr Nader Perroud, psychiatre spécialiste du TDAH, auteur notamment de TDAH, mode d'emploi aux Arènes BD et de Le TDAH chez l'adulte chez Eyrolles. Pendant 4 semaines, chaque vendredi, nous vous proposons d'explorer le TDAH dans toute sa richesse et sa complexité : ses multiples visages, le rôle du corps et des rythmes, l'influence des hormones chez les femmes, ainsi que l'intensité émotionnelle qui l'accompagne.Une citation avec le Pr Nader Perroud :"Il faut penser que certaines décompensations en période prémenstruelle sont peut-être un TDAH et pas simplement un syndrome prémenstruel."À réécouter : Oubliez tout ce que vous croyez savoir sur le TDAH Pourquoi le TDAH fait vivre si intensément ? Recevez chaque semaine l'inspirante newsletter Métamorphose par Anne GhesquièreDécouvrez Objectif Métamorphose, notre programme en 12 étapes pour partir à la rencontre de soi-même.Suivez nos RS : Insta, Facebook et TikTokAbonnez-vous sur Apple Podcasts / Spotify / Deezer / Castbox / YouTubeSoutenez Métamorphose en rejoignant la Tribu MétamorphoseThèmes abordés lors du podcast avec le Pr Nader Perroud :00:00Introduction02:04Pourquoi le TDAH des femmes est resté invisible si longtemps ?07:36Des symptômes internalisés11:12Hormones : le déclencheur caché du TDAH ?24:20Traitement hormonal ou psychostimulants ?29:20Les dernières découvertes de la scienceAvant-propos et précautions à l'écoute du podcast Photo DR Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Learn how dental practices lose thousands monthly through missed calls and inconsistent intake. Find out how diagnostic audits reveal hidden revenue leaks and why standardized systems can recover that lost patient demand before you spend another dollar on marketing. Client Revenue Flow City: Frisco Address: 8700 STONEBROOK PKWY PO BOX 309 Website: https://clientrevenueflow.com/

Dans cet épisode, Lénaïg Monier reçoit Guillaume Poitrinal, promoteur immobilier et président de la Fondation du Patrimoine. Alors que la France fait face à des incendies de forêt précoces et dévastateurs, il explique les actions menées pour replanter et protéger les forêts, notamment celle de Fontainebleau. Il évoque également les défis posés par le changement climatique pour le patrimoine bâti et les solutions à mettre en œuvre.L'invité souligne que les canicules deviennent de plus en plus longues et intenses, piégeant la chaleur dans les bâtiments en béton et en pierre, qui ont une forte inertie thermique. Il présente les avantages du bois, un matériau plus léger et sans inertie, permettant de rafraîchir naturellement les logements la nuit. Il insiste sur la nécessité d'adapter l'architecture et l'urbanisme pour lutter contre les îlots de chaleur, en favorisant la végétation, les couleurs claires et une conception bioclimatique des bâtiments.Il déplore que les réglementations actuelles, comme le Diagnostic de performance énergétique (DPE), soient encore trop focalisées sur les économies d'énergie et non sur l'adaptation au changement climatique. Il appelle à une évolution rapide des normes et des pratiques pour construire des villes plus résilientes, avec des bâtiments en matériaux biosourcés et une architecture méditerranéenne. Selon lui, cette transformation est indispensable pour attirer à nouveau les investisseurs et sortir de la crise immobilière.Malgré les alertes répétées des scientifiques et des ministres, Guillaume Poitrinal constate que les changements peinent à se concrétiser, en raison de l'inertie administrative et des lobbies. Il estime que ce sont finalement les populations, les salariés et les entreprises qui devront faire pression pour accélérer cette transition vers une ville plus durable et adaptée aux défis du climat.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Diagnostic et scan gratuit de votre écosystème pour identifier vos blocages et vos priorités : https://scan.flowtasking.fr/Le talent et le travail ne suffisent pas toujours pour réussir en entrepreneuriat. Dans cette vidéo, je parle des frustrations que vivent réellement les entrepreneurs : injustice, flops, insécurité financière, ghosting, impayés, administratif, conflits et haters.On nous apprend souvent que si nous travaillons bien, développons nos compétences et respectons les autres, les résultats finiront forcément par arriver.La réalité du business est beaucoup moins linéaire.Vous pouvez être compétent et mal vous vendre.Créer un excellent contenu que l'algorithme ignore.Faire correctement votre travail et être confronté à un impayé.Développer votre activité tout en continuant à ressentir une forte insécurité financière.Faire confiance à un associé, un client ou un partenaire qui ne respecte finalement pas ses engagements.Dans cette vidéo, je partage les principales frustrations que j'ai rencontrées depuis mes débuts dans l'entrepreneuriat, mais surtout les changements de posture, de processus et de système qui m'ont permis de mieux les traverser.Nous allons notamment parler de :Pourquoi la méritocratie fonctionne différemment dans le businessPourquoi le talent doit être associé à la vente, la visibilité et l'itérationComment gérer l'incertitude et l'insécurité financièreComment réduire le ghosting et mieux prévenir les impayésPourquoi les contrats, les acomptes et les limites sont indispensablesComment mieux gérer l'administratif en s'entourantComment choisir ses associés et partenaires selon leurs valeursComment réagir face aux conflits, aux trahisons et aux hatersL'objectif n'est pas de se plaindre. C'est de comprendre que ces frustrations font partie du jeu, de moins les prendre personnellement et de construire un business capable de mieux les absorber.

John Deere is committing to giving farmers diagnostic tools to help them and independent service technicians repair equipment, and China is once again placing U.S. soybean orders after a trade agreement ended the country's purchasing freeze.

Urmărește podcastul numărul de pe Acasă la Măruță, unde Cătălin Măruță îl are ca invitată pe Dr. Beatrice Anghel.#catalinmaruta #podcast #DrBeatriceAnghel

Please visit answersincme.com/KJW860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Aman Chauhan, MD and Rhonda K. Yantiss, MD. In this activity, experts in medical oncology and pathology discuss identification and treatment of extrapulmonary neuroendocrine carcinomas and extrapulmonary neuroendocrine tumors. Upon completion of this activity, participants should be better able to: Differentiate extrapulmonary neuroendocrine carcinoma (EP-NEC) from extrapulmonary neuroendocrine tumors (EP-NETs); Identify diagnostic and pathological approaches to improve the recognition and accurate classification of EP-NEC and EP-NET; Evaluate emerging clinical data on DLL3-targeting bispecific TCE agents in the treatment of EP-NEC and EP-NET; and Formulate evidence-based strategies to integrate DLL3-targeting bispecific TCE therapies into evolving treatment paradigms for EP-NEC and EP-NET.

The following article of the Tech industry is: 'Rare Diseases: The Urgent Need to Close Mexico's Diagnostic Gap' by Jorge Meléndez Zajgla, General Director, Instituto Nacional de Medicina Genomica. 

The National Peanut Board spent an energizing week with industry leaders in June at the 30th annual USA Peanut Congress, and an agreement announced by John Deere and the FTC ensures farmers and ranchers will have access to the diagnostic and repair tools to help maintain and repair equipment.

As the New World screwworm expands into the U.S. from Mexico, California's pest exclusion leaders already have developed a response plan, and an agreement announced by John Deere and the FTC ensures farmers and ranchers will have access to the diagnostic and repair tools to help maintain and repair equipment.

À 26 ans, la vie d'Annabelle bascule quand elle apprend qu'elle souffre d'un cancer agressif. Elle choisit d'affronter cette épreuve avec lucidité, de la comprendre, de l'accepter et de la documenter sur un compte Instagram qu'elle baptise @merci.cancer. Dans cet épisode, elle raconte le choc du diagnostic, celui des traitements, la stérilité annoncée suite aux chimiothérapies et sa lutte pour réaliser malgré tout son plus grand rêve : devenir mère.Vous aussi, vous voulez témoigner ? Contactez-nous par ici (ou au 0477 78 41 58 sur WhatsApp) et laissez-nous quelques mots sur votre histoire. Le respect de votre vie privée sera pleinement pris en compte. Vos propos seront recueillis dans un cadre bienveillant.Chaque semaine, Le Soir donne la parole aux 18-30 ans avec le podcast En vrai. Ils vous racontent une expérience ou une tranche de vie qui les a changés. Épisode après épisode, ils brossent un portrait de leur génération et de la société.

This week on the show, I share a diagnostic on a 2019 Subaru Impreza that has communication codes setting in the ABS module for several other modules on the car. The scan tool can talk with those modules, as well as the ABS. The ABS has been replaced with the same issue. Listen to find out the cause. Website- https://autodiagpodcast.com/Facebook Group- https://www.facebook.com/groups/223994012068320/YouTube- https://www.youtube.com/@automotivediagnosticpodcas8832Email- STmobilediag@gmail.comPlease make sure to check out our sponsors!SJ Auto Solutions- https://sjautosolutions.com/Automotive Seminars- https://automotiveseminars.com/L1 Automotive Training- https://www.l1training.com/Autorescue tools- https://autorescuetools.com/   

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this Mind Moments episode, Daniel Ontaneda, MD, PhD, professor of neurology at the Cleveland Clinic Mellen Center for Multiple Sclerosis, discusses a recently published study in Neurology evaluating the application of the 2024 McDonald Criteria in individuals with nonspecific neurologic symptoms or incidental MRI findings. Using data from the CAHPS-MS study, Ontaneda explains how the revised diagnostic criteria perform in these previously understudied patient populations and what the findings may mean for earlier identification of multiple sclerosis. The conversation explores the rationale behind expanding the 2024 McDonald Criteria, the role of central vein sign and cerebrospinal fluid oligoclonal bands in improving diagnostic confidence, and how clinicians should approach patients who fall into a diagnostic gray zone. Ontaneda also discusses the practical application of the updated criteria, the importance of longitudinal follow-up, and how emerging biomarkers may continue to refine MS diagnosis in the years ahead.  Looking for more Multiple sclerosis & demyelinating disorders discussion? Check out the NeurologyLive® Multiple sclerosis & demyelinating disorders clinical focus page.Episode Breakdown: 1:15 – Why the 2024 McDonald Criteria expanded diagnostic eligibility 4:30 – Applying the criteria in nonspecific symptom presentations 6:20 – Clinical relevance of symptom patterns and MRI findings 8:40 – Using biomarkers to improve diagnostic confidence 11:25 – Neurology News Minute  13:55– Interpreting dissemination in time with updated criteria 15:45 – Future validation of emerging MS diagnostic biomarkers The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Advisory Committee Schedules Meeting to Review Deramiocel's BLA in Duchenne Muscular Dystrophy FDA Clears PoNS Device for Stroke Rehabilitation, Expanding Neurostimulation Beyond MS Indication FDA Accepts Sarepta's sNDAs for Casimersen and Golodirsen for Duchenne Muscular Dystrophy Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

This week, Aebhric O'Kelly is joined by Bill Vasios and Rhod Jordan for an interactive discussion on one of the most important and often overlooked areas of remote medicine: Austere Primary Care.Whilst trauma often dominates training, the reality is that most remote clinicians spend far more time managing diarrhoeal illness, skin infections, musculoskeletal injuries, respiratory complaints, fever, environmental illnesses, and preventative healthcare. The panel discusses the clinical mindset required to work in resource-limited environments, introduces CoROM's CHART patient assessment system, and explores practical approaches to diagnosis when advanced investigations are unavailable.Whether you work in expedition medicine, offshore healthcare, humanitarian operations, military medicine, or remote primary care, this episode provides practical insights into becoming a more capable austere clinician.Chapters 00:05 – Welcome to CoROM Conversations00:17 – Why primary care matters more than trauma in remote medicine01:10 – Defining austere and resource-limited environments02:00 – Developing the austere clinical mindset02:40 – Becoming comfortable with uncertainty and limited resources04:00 – Building confidence through deliberate practice05:00 – Wilderness medicine and learning outside the ambulance07:15 – Resilience and supporting expedition teams08:00 – Common primary care presentations in austere environments08:15 – Gastrointestinal illness, dehydration and traveller's diarrhoea08:45 – Skin disease, wound care and blister management09:30 – Environmental illness: hypothermia, frostbite and heat injury10:10 – Musculoskeletal injuries in expedition medicine11:55 – Learning orthopaedic assessment through repetition13:00 – ENT, eye and dental emergencies14:20 – Introducing the CoROM CHART assessment framework16:40 – Chief Complaint, Condition and the CPRO assessment17:20 – Recognising the critically ill patient20:15 – History taking using SAMPLER with additional risk assessment22:00 – Secondary assessment using the BEAST observations26:10 – Review of systems using CRANES27:30 – Treatment, disposition and clinical trending28:10 – Diagnostic tools for austere medicine30:30 – Essential point-of-care investigations31:00 – Why every diagnostic tool needs a backup plan33:00 – Altitude, pulse oximetry and interpreting observations34:00 – Fever assessment in austere environments34:45 – Measuring temperature correctly in older adults and children35:40 – Managing fever of unknown origin and malaria36:10 – Nursing care and prolonged patient management36:45 – Public health and preventative medicine37:30 – Recognising clinical red flags38:00 – Key learning points and deployment preparation39:00 – The importance of clinical examination over technology40:00 – Trusting your senses and treating the patient—not the monitor41:00 – Closing remarks and CoROM CPD opportunitiesKey Topics DiscussedAustere primary careClinical reasoning in resource-limited environmentsThe austere clinical mindsetPreventative medicineTravel medicineWilderness medicineExpedition healthcareRemote diagnosticsFever of unknown originMalaria diagnosisEnvironmental medicineMusculoskeletal injuriesSkin diseasePoint-of-care ultrasoundNursing care in prolonged field careThe CoROM CHART assessment systemCPRO and BEAST observationsDifferential diagnosisKey TakeawaysMost remote clinicians spend considerably more time managing primary care conditions than major trauma.Clinical confidence develops through experience, deliberate practice and mentorship.Every piece of diagnostic equipment should have a backup plan.Careful history taking remains one of the most valuable diagnostic tools available.Trend observations over time rather than relying on single measurements.In malaria-endemic regions, malaria should remain high on the differential diagnosis for every patient with fever.

ll recouvre les deux-tiers de la planète, il nous semble mystérieux car nous ne voyons que sa surface : l'océan révèle petit à petit ses mystères au gré de l'amélioration des technologies pour l'explorer. Son immensité donne l'impression d'un géant invincible.  Il nous rend énormément de services : il nourrit une grande partie de l'humanité, il transporte 90% de nos marchandises, il régule le climat… mais nous le maltraitons à grande échelle et cela risque de se retourner contre nous. Nous vous emmènerons à la découverte du fantastique programme international ARGO qui collecte un maximum d'informations sur l'état de l'océan grâce à des milliers de balises réparties à travers le monde (reportage de Samuel Turpin) Avec l'éclairage de Jean-Pierre Gattuso, océanographe, directeur de recherche au CNRS, il travaille au laboratoire d'océanographie de Villefranche. Musique diffusée dans l'émission Lemon Demon - Deep in the ocean. Diaporama Les océans vont mal ! Leur température a augmenté en moyenne d'un demi-degré depuis 1970, favorisant notamment l'acidification des eaux. Résultats : les écosystèmes marins sont en danger. C'est ce que nous révèlent nombre d'études réalisées grâce aux données d'observation des océans, notamment celles réalisées par le programme ARGO que mène l'Institut de l'IFREMER, en France.   

Situé dans l'abdomen, le pancréas est une glande qui mesure 8 à 10 cm de long. C'est la 2e plus grosse glande de l'organisme après le foie. Elle fait partie du système digestif. Le pancréas joue un rôle dans la digestion et secrète l'insuline, hormone permettant de réguler la glycémie. Le cancer du pancréas, rare mais en forte augmentation, est souvent diagnostiqué à un stade avancé, ce qui implique une forte létalité. Lors du rendez-vous majeur de l'oncologie mondiale, l'ASCO de Chicago, qui réunit près de 40 000 chercheurs, les résultats prometteurs d'un essai clinique portant sur l'efficacité d'un traitement innovant, le daraxonrasib, a suscité l'enthousiasme parmi les congressistes. Ce médicament doublerait la durée de survie des patients atteints d'adénocarcinome pancréatique métastatique. Comment expliquer que le diagnostic du cancer du pancréas soit le plus souvent tardif ? Aujourd'hui, quelles sont les pistes pour améliorer les chances de survie des patients diagnostiqués pour un cancer du pancréas ? Avec: Pr Pascal Hammel, Chef du Service d'Oncologie Digestive et Médicale à l'Hôpital Paul Brousse, à Villejuif en région parisienne Retrouvez l'émission en podcast ici : Cancer du Pancréas : pourquoi de nouvelles pistes de traitement suscitent l'espoir

Indolent systemic mastocytosis (ISM) is a rare form of systemic mastocytosis (SM) caused by an abnormal buildup of mast cells throughout the body. What causes ISM, and how is it diagnosed? In this episode, we speak with Aaron Gerds, MD, Associate Professor of Medicine in Hematology and Medical Oncology at the Cleveland Clinic Cancer Institute, about the signs and symptoms of ISM, the diagnostic process, and how ISM differs from other forms of systemic mastocytosis. We also hear from Candice Pauley, an ISM patient and co-host of the Mast Cast Pod, who shares her journey to diagnosis, her experience living with the disease, and the challenges of navigating a rare condition. Credits Host: Neha Pathak, MD, FACP, DipABLM Producer/Editor: Matt Stillo Show Notes: Lauren Summers Guests: Aaron Gerds, MD; Candice Pauley See omnystudio.com/listener for privacy information.

This month we begin a new series on Postural Orthostatic Tachycardia Syndrome (POTS), exploring the diagnosis and management of this increasingly recognized condition in pediatric patients. In this episode, host Paul Wirkus, MD, FAAP and guest Kirti Sivakoti, MD, provide an overview of POTS before discussing current approaches to diagnosis and recent updates in the field. We review the diagnostic criteria, including orthostatic symptoms and the degree of functional impairment, and consider how these factors help guide clinical evaluation and management.The conversation also examines the growing understanding of POTS as a spectrum disorder, with many patients experiencing overlapping symptoms and contributing conditions. Finally, we discuss how to distinguish POTS from vasovagal syncope and review current thinking on the underlying causes and pathophysiology of POTS. This episode provides pediatricians with a practical framework for recognizing and evaluating children and adolescents with orthostatic intolerance.Have a question? Email questions@vcurb.com. Listener questions will be answered in episode four. For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Căutarea unui diagnostic poate fi, de multe ori, o cursă cu obstacole. Multe obstacole. Nu vi s-a întâmplat să fiți trimiși de la medic la medic, de la analiză la analiză, iar asta să vă facă să renunțați? Nu vi s-a întâmplat să vă descurajeze, în căutarea unui diagnostic, poate chiar medicul care v-a repezit sau poate v-a certat sau v-a spus direct, în față, fără menajamente, numele vreunei boli la care nici nu vă gândeați? În România, în fiecare an, aproximativ 500 de oameni la suta de mii de locuitori mor cu zile din cauza unor boli care puteau fi prevenite sau pentru care există tratament. Printre cauze și diagnosticarea târzie. Adică depistarea unei boli în fază avansată, mult prea târziu pentru ca pacientul să poată fi salvat. Vorbim despre labirintul printre analize și investigații.

Dr. Greg Cooper and Dr. Elisabeth Kurpershoek discuss how clinicians communicate uncertainty during Parkinson's disease diagnosis and how this impacts patient trust and understanding.  Show citation:  Hillen MA, Kurpershoek E, Huisman MHB, et al. Clinician Communication About Uncertainty During Parkinson Disease Diagnostic Consultations. Neurol Clin Pract. 2026;16(3):e200613. doi:10.1212/CPJ.0000000000200613 

Dr. Greg Cooper talks with Dr. Elisabeth Kurpershoek about how clinicians communicate uncertainty during Parkinson disease diagnosis and how this impacts patient trust and understanding.  Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.  

Families seeking a diagnosis for a rare disease often face a protracted diagnostic odyssey that can include ER visits, specialist referrals, and dead ends, even at world-class medical centers. Parents bounce from doctor to doctor while payers absorb mounting costs, and the pivotal moment of putting a name to a disease—which can reduce unnecessary care and emotional distress—arrives late, if at all. Sunstone Health is seeking to industrialize the path to answers by using AI to scan claims data for patterns that flag likely genetic disease, recruiting high-risk families, and fast-tracking whole-genome sequencing through a top clinical lab. Sunstone Health founder Joshua Resnikoff discusses how his son's rare disease diagnostic odyssey gave rise to the company, how Sunstone is working to transform the path to a diagnosis, and its business model of relying on the savings it delivers to self-funded employers.

In this episode, host Don Adeesha sits down with Dr. Tiffany Hall, Chief Growth Officer at Aesthetic Record, to dismantle the biggest myth in medical aesthetics: that revenue is the number that decides whether a practice survives. Dr. Hall, who sits on top of one of the largest pools of real-world operational data in the industry, argues that most owners misdiagnose a marketing problem when the real bleed is happening at the operational and follow-up layer. She walks through the exact data trail an owner can pull tomorrow morning, speed to lead, conversion, retention, and frequency of visit, and explains why "fishing in your own pond" beats chasing new leads every time. From the 2.5-visits-per-year golden number to the 80% utilization sweet spot to the inventory and COGS metrics a PE firm scrutinizes during due diligence, this is a tactical map of where revenue hides inside your own EMR. Dr. Hall closes with her one Monday-morning fix for any owner staring down 24 months to scale, sell, or stall: run your 12-month inactivity report, find every patient who came in once for one thing, and start re-engaging them. The data is the goldmine, most owners just never sit down and dig.

In this interview, Dr. Roopa Sharma, MD, interviews with Hans D. Katzberg, MD—Professor of Medicine and Head of the Division of Neurology at University Health Network and the University of Toronto—about his recent article and the AANEM guideline published in Muscle & Nerve, titled “Diagnostic and Screening Laboratory Tests in the Assessment of Patients with Small Fiber Neuropathy: An Evidence-Based Review—Report of the AANEM Small Fiber Neuropathy Task Force.

In this episode, Anthony and Bernie are joined by the great Dr. Bixby to discuss the difficulties in the diagnosis and treatment of acute leukemias of mixed or ambiguous lineage (ALAL/MPAL). We discuss:- Diagnostic uncertainties and how the criteria for diagnosis have changed over the years- Data behind the optimal treatment of MPAL and uncertainties in the literature- Promising data for the FLAG-VIPR hybrid regimen and other novel treatment strategies

Téléchargez mon template Notion gratuit pour créer une offre de A à Z : http://thebboost.fr/376Votre offre ne se vend pas, ou pas assez ? Avant de la reconstruire de fond en comble, écoutez ça : 8 fois sur 10, retravailler son offre, c'est exactement la mauvaise réponse.Parce que le problème, bien souvent, ce n'est pas votre offre. C'est votre promesse, ou votre marketing. Et reconstruire une offre qui avait tout pour fonctionner, c'est de la procrastination déguisée.Dans cet épisode, on commence par un diagnostic clair pour identifier d'où vient VRAIMENT le problème (promesse, marketing ou offre). Ensuite, on déroule le tuto complet pour construire une offre qui se vend en 2026 : moderne, adaptée à l'ère de l'IA, et calibrée sur votre marché.✨ Au programme :00:00 - Introduction00:42 - Et si le problème n'était pas votre offre ?03:11 - Les 3 coupables : promesse, marketing ou offre06:49 - Comment savoir lequel vous empêche de vendre09:05 - Étape 1 : votre cible, ses besoins vs. ses envies15:31 - Étape 2 : choisir votre business model17:52 - Étape 3 : votre promesse (l'étape qui fait tout)19:17 - Étape 4 : structurer votre offre sans la surcharger24:01 - Étape 5 : fixer votre tarif28:08 - Les 3 non-négociables d'une offre qui se vend en 202634:02 - Les 4 erreurs qui tuent vos ventes✨ Liens et références cités dans l'épisode :Mon template Notion offertMon épisode sur les tarifs

Drop us a message!In many B2B sectors, marketing has always been treated as a cost rather than a commercial driver, and the businesses that change that thinking are the ones that start pulling ahead.In this episode of Social In 10, we're joined by Alastair Patrick, Founder of Aluxai, to explore what it really takes to build a marketing function from first principles in sectors where marketing has historically been undervalued.Alastair shares how businesses can move from relying on relationships and reputation to building a structured, full-funnel demand engine, the diagnostic questions he asks when stepping into an undermarketed sector to uncover the biggest commercial opportunities, and how founder-led businesses can introduce senior-level marketing thinking without creating unnecessary complexity or overhead. You can find Alastair online via the links below:Website: aluxai.co.ukLinkedIn: linkedin.com/in/alastairpatrick1Want to be featured on the pod? Drop us a voice note on Instagram at @GiraffeSM.About Giraffe Social's Social in 10 PodcastGiraffe Social is a multi-disciplined digital marketing agency specialising in social media marketing based on the South Coast of the United Kingdom. We work with a wide range of industries, spanning from Fintech and L&D, to Beauty and Retail.Social in 10 is a weekly podcast about all things digital marketing. We discuss all the things social media managers want to know, including the latest platform updates, emerging trends, campaign ideas, and best practices to help you stay ahead of the curve. Whether you're managing multiple clients or growing your brand in-house, each episode is packed with actionable insights… all delivered in under ten minutes.Hosted by the Giraffe Social team, this is your fast, fun, no-fluff guide to making sense of social. New episodes every week, so tune in and level up your marketing game!

How do expert clinicians actually think? Why do diagnostic errors happen? And can artificial intelligence improve clinical reasoning without replacing physicians? In this episode of The Lebanese Physicians Podcast, I sit down with Dr. Raja-Elie Abdulnour, Pulmonary and Critical Care Physician at the Brigham and Women's Hospital and Editor-in-Chief of NEJM Clinician and Chief Clinical Innovation Officer NEJM Group , to explore the evolving relationship between clinical reasoning and AI. We discuss how physicians develop diagnostic expertise, the cognitive biases behind medical errors, the rise of AI-powered clinical decision support tools, the future of augmented intelligence in healthcare, and why human judgment, communication, and trust remain essential in medicine. Whether you're a medical student, resident, practicing clinician, or simply curious about the future of healthcare, this conversation offers valuable insights into how AI may transform the way we diagnose, learn, and care for patients. Topics Covered: How expert clinicians think System 1 vs. System 2 reasoning Diagnostic errors and cognitive biases AI performance in clinical diagnosis ChatGPT and medical decision-making AI scribes and workflow efficiency Augmented intelligence in healthcare The future of physician-AI collaboration Preserving clinical skills in the AI era #ClinicalReasoning #ArtificialIntelligence #AIinMedicine #MedicalEducation #HealthcareInnovation #ChatGPT #NEJM #MedicalAI #DiagnosticReasoning #AugmentedIntelligence #PhysicianLeadership #DigitalHealth #PulmonaryCriticalCare #TheLebanesePhysiciansPodcast #MedicineFuture On YouTube @thelebanesephysicianspodcast @nejmgroup

In this episode of Around the Rheum, hosts Dr. Daniel Ennis and Dr. Janet Pope sit down with Dr. Luke Chen for a deep dive into an approach to patients presenting with hypereosinophilia. Recorded at the Canadian Rheumatology Association (CRA)'s 2026 Annual Scientific Meeting in Halifax, the conversation explores how hematologists, rheumatologists, allergists, infectious disease specialists, and others work together to diagnose and manage these complex disorders.Dr. Chen discusses the broad differential diagnosis behind eosinophilia — from Eosinophilic Granulomatosus with Polyangiitis (EGPA) and IgG4-related disease to parasitic infections to rare hematologic disorders to 'Idiopathic' Hypereosinophilic Syndrome (I-HES) — and the uncertainty clinicians often face when distinguishing overlapping eosinophilic diseases. The discussion also highlights emerging therapies including IL-5 inhibitors, JAK inhibitors, interferon, and biologics, alongside the practical realities of access to treatment in rare disease care.Thoughtful, practical, and candid, this episode offers insight into multidisciplinary medicine, diagnostic humility, and caring for patients living with rare inflammatory diseases. It touches on the importance of being okay with uncertainty in the rare disease space.Dr. Luke Chen is a hematologist and Professor of Medicine at Dalhousie University in Halifax, Nova Scotia. His clinical and research interests focus on rare inflammatory diseases and eosinophilic disorders. He is the founder of the Coastal Rare Inflammatory Diseases Program, supporting physicians caring for patients with rare diseases across Canada.Around The Rheum is produced by the CRA Communications Committee. A special thank you to the podcast team, Dr. Dax G. Rumsey (CRA Communications Committee Chair), Dr. Daniel Ennis (Host), Dr. Janet Pope (Host), David McGuffin of Explore Productions, and Erin Stewart (CRA) for leading production.Our theme music was composed by Aaron Fontwell.For more on the work of the Canadian Rheumatology Association, visit rheum.ca.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Isaac George, CTSNet Board Member and Co-Director of the Structural Heart and Valve Center, Surgical Director of Structural Heart Disease, and Co-Director of the Mitral and Tricuspid Center at Columbia University Medical Center/NewYork-Presbyterian, NY, USA, about the lifetime management of aortic valve disease. Chapters 00:00 Intro 02:11 AATS-CTSN Randomized Trials 04:37 JANS 1, Consensus Statement ALAD 10:28 JANS 2, Lung Re-Transplantation Outcomes 12:19 JANS 3, Aortic Homografts, EURECAH 15:15 JANS 4, Lobectomy Cost Analysis 18:10 Video 1, Anomalous L Coronary Artery 19:38 Video 2, Pulm Valve Replacement Reop 21:38 Video 3, Giant Pulm Artery Aneurysm 23:28 Dr. George Discussion 33:18 Upcoming Events 34:05 Closing They explored the expansion of transcatheter aortic valve replacement (TAVR), emphasizing the crucial role of the heart valve team in this process. The discussion highlighted the necessity for surgeons to be actively involved in the decision-making process surrounding TAVR, particularly in the early stages. They also addressed the importance of lifetime management of the valve, selecting the appropriate valve, and valve durability. Additionally, they discussed the significance of providing patients with multiple surgical options, the Ross procedure, mechanical valves, and explored which procedures patients are choosing. Joel also highlights recent JANS articles on the ISHLT consensus statement on acute lung allograft dysfunction, aortic homografts for native and prosthetic aortic valve and root endocarditis, how outcomes after lung re-transplantation for restrictive allograft syndrome have not improved over two decades, and the financial burden of postoperative adverse events following lobectomy. In addition, Joel explores the surgical repair of an anomalous left coronary artery from the right pulmonary artery, minimally invasive pulmonary valve replacement in reoperative settings, and surgical management of giant pulmonary artery aneurysm using a T-shaped graft-valve strategy. Before closing, Joel highlights upcoming events in CT surgery. JANS Items Mentioned ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities Aortic Homografts for Native and Prosthetic Aortic Valve and Root Endocarditis: Results From the EUropean REgistry of Cryopreserved Aortic Homografts EURECAH Outcomes After Lung Re-Transplantation for Restrictive Allograft Syndrome Have Not Improved Over Two Decades Financial Burden of Postoperative Adverse Events Following Lobectomy: Cost Analysis From 10 High-Volume Canadian Hospitals CTSNet Content Mentioned Surgical Repair of an Anomalous Left Coronary Artery From the Right Pulmonary Artery Minimally Invasive Pulmonary Valve Replacement in Reoperative Settings Surgical Management of Giant Pulmonary Artery Aneurysm Using a T-Shaped Graft-Valve Strategy Other Items Mentioned CTSNet Innovation Video Competition Career Center CTSNet Events   Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Looking to strengthen your veterinary dentistry skills and improve patient outcomes? Access our FREE RACE-accredited online veterinary dentistry course and join thousands of veterinary professionals advancing their dental knowledge. https://ivdi.org/free --- Host: Dr. Brett Beckman, DVM, FAVD, DAVDC, DAAPM Guest: Annie Mills, LVT --- Client communication and home care compliance are among the most important factors influencing long-term success in veterinary dentistry. In this episode, Annie Mills, LVT, answers questions submitted during recent online trainings and shares practical strategies for improving client education, increasing treatment acceptance, and helping pet owners become active participants in their pet's oral health. The episode also explores evidence-based home care recommendations, including the role of Veterinary Oral Health Council (VOHC) approved products, practical options for dogs and cats, and why home care should be viewed as an essential component of every dental treatment plan. Annie also addresses common objections to dental radiography and explains why comprehensive assessment and diagnosis must take priority over cosmetic cleaning alone. Whether you're looking to improve client communication, increase follow-up compliance, or strengthen your preventive dentistry protocols, this episode provides practical guidance you can immediately apply in general practice. What You'll Learn in This Episode

Send us Fan MailIn this episode, Bryn, Ralph, Will and Marcus discuss some of the changes in the way M&P equipment should be diagnosed on the new equipment.Thanks for listening!  Please visit www.mitsubishicomfort.comContact us at metustechshow@hvac.mea.com

PainExam Podcast Show Notes NAD+ Supplementation in Pain and Inflammation: Hype, Hope, or Emerging Science? Hosted by: PainExam Podcast Presented by: NRAP Academy (Neuromodulation, Regional Anesthesia & Pain) Host: David Rosenblum, MD Episode Overview In this episode of the PainExam Podcast, we explore the growing interest in NAD+ (Nicotinamide Adenine Dinucleotide) supplementation and its potential role in pain management, inflammation reduction, cellular recovery, and healthy aging. NAD+ is a naturally occurring coenzyme found in every living cell and is essential for energy production, mitochondrial function, DNA repair, and cellular resilience. As NAD+ levels decline with age, chronic stress, inflammation, and disease, researchers have begun investigating whether restoring NAD+ levels may improve outcomes in chronic pain conditions and inflammatory disorders. We review the current science, discuss potential mechanisms of action, and examine how NAD+ therapy is being integrated into regenerative medicine, wellness programs, and pain management practices. What is NAD+? NAD+ is a coenzyme involved in: ✅ Cellular energy production (ATP generation) ✅ Mitochondrial health ✅ DNA repair pathways ✅ Oxidative stress reduction ✅ Neuroprotection ✅ Cellular signaling ✅ Activation of longevity-associated proteins called sirtuins Without adequate NAD+, cells become less efficient at producing energy and managing inflammation. Why Might NAD+ Matter in Chronic Pain? Many chronic pain conditions involve: Mitochondrial dysfunction Oxidative stress Neuroinflammation Peripheral and central sensitization Impaired cellular recovery Researchers hypothesize that optimizing NAD+ levels may help address several of these pathways simultaneously. Potential areas of interest include: Neuropathic Pain NAD+ may support: Nerve repair Axonal recovery Mitochondrial function within neurons Reduction of oxidative injury Inflammatory Pain NAD+ influences inflammatory signaling pathways and may help modulate: Cytokine production Immune cell activity Cellular stress responses Fatigue and Recovery Patients with chronic pain frequently report: Fatigue Brain fog Reduced exercise tolerance Poor recovery Because NAD+ plays a critical role in energy metabolism, some clinicians report improvements in energy and recovery following supplementation. Potential Mechanisms of Action 1. Improved Mitochondrial Function Mitochondria generate ATP, the body's energy currency. Reduced NAD+ levels are associated with: Cellular aging Impaired energy production Increased inflammation Supplementation may help restore mitochondrial efficiency. 2. Activation of Sirtuins Sirtuins are proteins involved in: Cellular repair Longevity Metabolic regulation Inflammation control NAD+ serves as a critical substrate for sirtuin activity. 3. DNA Repair Support NAD+ is required for enzymes known as PARPs (Poly ADP Ribose Polymerases), which participate in DNA repair processes following cellular injury. 4. Reduction of Oxidative Stress Chronic inflammation often produces excessive reactive oxygen species (ROS). NAD+ may help maintain cellular antioxidant defenses and reduce oxidative injury. Routes of NAD+ Supplementation Intravenous (IV) NAD+ Most commonly marketed in wellness and recovery clinics. Potential advantages: Direct systemic delivery Avoids gastrointestinal absorption issues Allows higher dosing protocols Potential limitations: Cost Time commitment Variable evidence base Oral Precursors Rather than NAD+ itself, many supplements provide precursors such as: Nicotinamide Riboside (NR) Nicotinamide Mononucleotide (NMN) These compounds are converted into NAD+ within the body. What Does the Evidence Show? Current evidence remains preliminary. While preclinical and mechanistic studies are promising, large-scale randomized controlled trials evaluating NAD+ specifically for chronic pain are still limited. Areas under active investigation include: Neuropathic pain Neurodegenerative disorders Chronic fatigue syndromes Recovery optimization Healthy aging Patients should understand that NAD+ therapy remains an emerging treatment rather than a standard evidence-based pain intervention. Safety Considerations Reported side effects may include: Nausea Flushing Chest tightness during rapid infusions Headache Fatigue Lightheadedness Most adverse effects appear infusion-rate dependent and can often be minimized through slower administration protocols. Patients should discuss treatment with a qualified healthcare professional, especially if they have: Cardiovascular disease Active cancer Significant medical comorbidities Clinical Pearls for Pain Physicians ✔ Consider NAD+ as a potential adjunct—not a replacement—for evidence-based pain care. ✔ Continue emphasizing exercise, sleep optimization, nutrition, behavioral health, and appropriate interventional therapies. ✔ Discuss realistic expectations with patients. ✔ Recognize that evidence continues to evolve. ✔ Focus on patient-centered outcomes rather than laboratory markers alone. Key Takeaways NAD+ is essential for cellular energy production and repair. Declining NAD+ levels may contribute to aging, inflammation, and chronic disease. Early evidence suggests possible benefits in inflammation, recovery, fatigue, and nerve health. Robust pain-specific clinical trials remain limited. NAD+ therapy should currently be viewed as an adjunctive and investigational strategy in pain management. Resources for Physicians Pain Medicine Board Preparation Prepare for the ABA Pain Medicine Boards with:

    PainExam Podcast Show Notes NAD+ Supplementation in Pain and Inflammation: Hype, Hope, or Emerging Science? Hosted by: PainExam Podcast Presented by: NRAP Academy (Neuromodulation, Regional Anesthesia & Pain) Host: David Rosenblum, MD Episode Overview In this episode of the PainExam Podcast, we explore the growing interest in NAD+ (Nicotinamide Adenine Dinucleotide) supplementation and its potential role in pain management, inflammation reduction, cellular recovery, and healthy aging. NAD+ is a naturally occurring coenzyme found in every living cell and is essential for energy production, mitochondrial function, DNA repair, and cellular resilience. As NAD+ levels decline with age, chronic stress, inflammation, and disease, researchers have begun investigating whether restoring NAD+ levels may improve outcomes in chronic pain conditions and inflammatory disorders. We review the current science, discuss potential mechanisms of action, and examine how NAD+ therapy is being integrated into regenerative medicine, wellness programs, and pain management practices. What is NAD+? NAD+ is a coenzyme involved in: ✅ Cellular energy production (ATP generation) ✅ Mitochondrial health ✅ DNA repair pathways ✅ Oxidative stress reduction ✅ Neuroprotection ✅ Cellular signaling ✅ Activation of longevity-associated proteins called sirtuins Without adequate NAD+, cells become less efficient at producing energy and managing inflammation. Why Might NAD+ Matter in Chronic Pain? Many chronic pain conditions involve: Mitochondrial dysfunction Oxidative stress Neuroinflammation Peripheral and central sensitization Impaired cellular recovery Researchers hypothesize that optimizing NAD+ levels may help address several of these pathways simultaneously. Potential areas of interest include: Neuropathic Pain NAD+ may support: Nerve repair Axonal recovery Mitochondrial function within neurons Reduction of oxidative injury Inflammatory Pain NAD+ influences inflammatory signaling pathways and may help modulate: Cytokine production Immune cell activity Cellular stress responses Fatigue and Recovery Patients with chronic pain frequently report: Fatigue Brain fog Reduced exercise tolerance Poor recovery Because NAD+ plays a critical role in energy metabolism, some clinicians report improvements in energy and recovery following supplementation. Potential Mechanisms of Action 1. Improved Mitochondrial Function Mitochondria generate ATP, the body's energy currency. Reduced NAD+ levels are associated with: Cellular aging Impaired energy production Increased inflammation Supplementation may help restore mitochondrial efficiency. 2. Activation of Sirtuins Sirtuins are proteins involved in: Cellular repair Longevity Metabolic regulation Inflammation control NAD+ serves as a critical substrate for sirtuin activity. 3. DNA Repair Support NAD+ is required for enzymes known as PARPs (Poly ADP Ribose Polymerases), which participate in DNA repair processes following cellular injury. 4. Reduction of Oxidative Stress Chronic inflammation often produces excessive reactive oxygen species (ROS). NAD+ may help maintain cellular antioxidant defenses and reduce oxidative injury. Routes of NAD+ Supplementation Intravenous (IV) NAD+ Most commonly marketed in wellness and recovery clinics. Potential advantages: Direct systemic delivery Avoids gastrointestinal absorption issues Allows higher dosing protocols Potential limitations: Cost Time commitment Variable evidence base Oral Precursors Rather than NAD+ itself, many supplements provide precursors such as: Nicotinamide Riboside (NR) Nicotinamide Mononucleotide (NMN) These compounds are converted into NAD+ within the body. What Does the Evidence Show? Current evidence remains preliminary. While preclinical and mechanistic studies are promising, large-scale randomized controlled trials evaluating NAD+ specifically for chronic pain are still limited. Areas under active investigation include: Neuropathic pain Neurodegenerative disorders Chronic fatigue syndromes Recovery optimization Healthy aging Patients should understand that NAD+ therapy remains an emerging treatment rather than a standard evidence-based pain intervention. Safety Considerations Reported side effects may include: Nausea Flushing Chest tightness during rapid infusions Headache Fatigue Lightheadedness Most adverse effects appear infusion-rate dependent and can often be minimized through slower administration protocols. Patients should discuss treatment with a qualified healthcare professional, especially if they have: Cardiovascular disease Active cancer Significant medical comorbidities Clinical Pearls for Pain Physicians ✔ Consider NAD+ as a potential adjunct—not a replacement—for evidence-based pain care. ✔ Continue emphasizing exercise, sleep optimization, nutrition, behavioral health, and appropriate interventional therapies. ✔ Discuss realistic expectations with patients. ✔ Recognize that evidence continues to evolve. ✔ Focus on patient-centered outcomes rather than laboratory markers alone. Key Takeaways NAD+ is essential for cellular energy production and repair. Declining NAD+ levels may contribute to aging, inflammation, and chronic disease. Early evidence suggests possible benefits in inflammation, recovery, fatigue, and nerve health. Robust pain-specific clinical trials remain limited. NAD+ therapy should currently be viewed as an adjunctive and investigational strategy in pain management. Resources for Physicians Pain Medicine Board Preparation Prepare for the ABA Pain Medicine Boards with:

A cartoon pig ran one of the most integrated campaigns I've seen in years—and it still leaves the most important question unanswered. In this week's Spin Sucks podcast episode, I run the Peppa Pig pregnancy campaign through the PESO Model® Diagnostic to show you the difference between a brilliant campaign and an actual operating system: one has a finale, the other never ends.  Take the PESO Model® Diagnostic: https://spinsucks.com/self-peso-diagnostic/  Explore the PESO Model® Certification: https://spinsucks.com/peso-model-certification/  Read the full article: https://spinsucks.com/communication/peso-model-diagnostic-peppa-pig

Vascular access is the lifeline for people on dialysis. Today we'll cover the different types, how doctors determine the best option, what the surgery and recovery involve, and more! Today we're joined by Dr. Vandana Dua Niyyar, and kidney warrior Brittany Dickerson to discuss vascular access–an important topic that will hopefully help you all listening feel more informed and confident in your care.  In today's episode we heard from:  Vandana Dua Niyyar is Professor of Medicine in the Division of Nephrology and has received the Clinical Distinction of Master Physician at Emory University. Dr. Niyyar is passionate about promoting multidisciplinary collaboration in research and education in the field of vascular access; with the ultimate goal of optimizing access care and processes for dialysis patients. She currently serves as Immediate Past President of the American Society of Diagnostic and Interventional Nephrology (ASDIN). Dr. Niyyar has been recognized for her exemplary clinical and service achievements through various awards including ASDIN Distinguished Service Award in 2019, Emory Nanette Wenger Service Award in 2019, ASN Mid-Career Distinguished Clinical Service Award in 2020, ANIO Clinical Excellence Award in 2021, Emory DOM Outstanding Quality Achievement Award in 2022 and and ASDIN Gerald Beathard Award in recognition of her teaching excellence, scholarly activity, and clinical excellence in 2024. Brittany Dickerson- I am a dedicated mother, motivational speaker, and compassionate life coach living with Polycystic Kidney Disease (PKD). I use my kidney failure battle to educate and help others regarding kidney disease and transplantation. My personal journey has fueled my passion for helping others navigate life's challenges with courage and grace. Through partnership with the National Kidney Foundation, I have had the opportunity to mentor others and to be a guest for the National Kidney Foundation Podcast channel. My dedication to kidney awareness has led me to pursue becoming a National Kidney Foundation Advocate. I use my voice to spread my powerful message of perseverance and hope. My goal is to continue making an impact on individuals facing adversity, offering guidance, support, and being a shining example of strength in the face of hardship.   Additional Resources Vascular Access Guidelines   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.  

Q-BANK: https://www.patreon.com/highyieldfamilymedicineIntro (0:35),Definition (1:44),PALM-COEIN (2:48),Diagnostic approach (3:51),Endometrial polyps (5:39),Adenomyosis (7:37),Endometriosis (9:40),Leiomyoma (11:28),Endometrial hyperplasia and cancer (13:37), Coagulopathy (15:59),Polyendocrine Metabolic Ovarian Syndrome (17:20),Iatrogenic (20:02),Practice Questions (21:22)

Send us Fan MailA splenic mass shows up on ultrasound and the question hits like a brick: benign or malignant? We go straight at the uncomfortable truth behind canine splenic cytology. Even when splenic FNA feels like the “do something now” step, the match between cytology and histopathology is only moderate, and that has consequences for how we advise families, schedule rechecks, and decide when splenectomy is the safest path.We talk with Drs. Janet Grimes and Matthew Aluisio about what their data means in the exam room: why a neoplastic cytology result tends to be more predictive than a non-neoplastic one, and why a benign aspirate does not rule out cancer. We unpack the spleen's built-in complexity, including extramedullary hematopoiesis, mixed cell populations, and the sampling problem of trying to summarize a large, heterogeneous lesion from a tiny needle sample. We also get specific about the diagnoses no one wants to miss, including hemangiosarcoma and lymphoma, and how tumor exfoliation and overlap with reactive processes can blur the picture.From there, we shift into action: when cytology is most useful, when serial ultrasound monitoring is a reasonable strategy for smaller, non-ruptured nodules, and when size and rupture risk should move the conversation toward surgery and definitive histopathology. We also dig into the “possibly neoplastic” gray zone and why calling your pathologist can be one of the most practical diagnostic tools you have.If you work up splenic masses in dogs and want clearer owner conversations, better monitoring plans, and fewer false reassurances, this one is for you. Subscribe, share with a colleague, and leave a rating and review so more clinicians can find the show.JAVMA article: https://doi.org/10.2460/javma.26.01.0006INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ®  OR AJVR ® ?JAVMA ® : https://avma.org/JAVMAAuthorsAJVR ® : https://avma.org/AJVRAuthorsFOLLOW US:JAVMA ® :Facebook: Journal of the American Veterinary Medical Association - JAVMA | FacebookInstagram: JAVMA (@avma_javma) • Instagram photos and videosTwitter: JAVMA (@AVMAJAVMA) / Twitter AJVR ® : Facebook: American Journal of Veterinary Research - AJVR | FacebookInstagram: AJVR (@ajvroa) • Instagram photos and videosTwitter: AJVR (@AJVROA) / TwitterJAVMA ®  and AJVR ®  LinkedIn: https://linkedin.com/company/avma-journals

Commentary by Dr. Jian'an Wang.

Merci à Mammouth AI d'avoir sponsorisé cet épisode : ⁠https://mammouth.ai⁠Sébastien Martinez est champion de France de mémoire et expert en techniques de mémorisation et d'apprentissage. Son dernier livre La mémoire est un jeu est disponible partout (lien ci-dessous).⁠Site Internet⁠⁠Youtube⁠⁠Instagram⁠⁠Livre (Amazon)⁠CHAPITRES :0:00 Introduction2:35 Mémoire et technologies5:41 Autonomie face au numérique13:28 Réserve cognitive et Alzheimer16:24 Retenir les prénoms20:07 Le GPS sous examen28:03 Calculer sans la calculatrice31:51 Sommeil et consolidation38:00 Le test de rappel39:25 Le palais mental43:42 Mémoriser les chiffres46:41 Utilité au quotidien48:20 Mémoire et métiers50:07 Acteurs et textes à retenir54:02 Retenir les prénoms, d'abord59:25 Codes et chiffres en images1:03:26 Retrouver les objets perdus1:14:40 Vérifier la porte fermée1:21:38 Apprendre une langue1:28:35 Mythes sur les types de mémoire1:32:55 Alimentation1:35:41 Diagnostic des problèmes mnésiquesBIOMÉCANIQUE :​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Discord⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠​⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠La Lettre Biomécanique⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠™⁠⁠ Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

In this episode of PICU Doc on Call, hosts Dr. Monica Gray and Dr. Pradip Kamat explore procedural sedation in the pediatric ICU. They cover sedation levels, pre-screening, risk stratification using ASA classifications, and medication selection tailored to each patient's hemodynamic and respiratory status. Through real-world case discussions involving respiratory failure, septic shock, and acute neurological decline, they highlight the importance of end-tidal CO2 monitoring and early adverse event recognition. Key takeaways include avoiding the term "conscious sedation," preparing rescue plans, and prioritizing patient safety through careful assessment and monitoring.Show Highlights:Definitions and levels of sedation (minimal, moderate, deep sedation, and general anesthesia)Importance of terminology in procedural sedationMonitoring sedation levels using scales like the Richmond Agitation-Sedation Scale (RASS)Pre-screening and risk stratification considerations for pediatric patientsASA physical status classification system for assessing patient riskUnique challenges of procedural sedation in critically ill childrenAdverse events associated with pediatric procedural sedation, particularly respiratory complicationsManagement strategies for specific cases requiring sedation (e.g., respiratory failure, septic shock)Importance of end-tidal CO2 monitoring during sedationKey takeaways for safe sedation practices in the pediatric ICU settingReferences: Nir Atlas; Rahul C. Damania; Pradip P. Kamat In Fuhrman & Zimmerman - Textbook of Pediatric Critical Care Chapter 135, 1624-1628Statement on Continuum of Depth of Sedation: Definition of General Anesthesia and Levels of Sedation/Analgesia by Committee on Quality Management and Departmental Administration. Last Amended: October 23, 2024.Coté CJ, Wilson S; AMERICAN ACADEMY OF PEDIATRICS; AMERICAN ACADEMY OF PEDIATRIC DENTISTRY. Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures. Pediatrics. 2019 Jun;143(6):e20191000. doi: 10.1542/peds.2019-1000. PMID: 31138666.xKrauss B, Green SM. Procedural sedation and analgesia in children. Lancet. 2006 Mar 4;367(9512):766-80. doi: 10.1016/S0140-6736(06)68230-5. PMID: 16517277.Sharif S, Kang J, Sadeghirad B, Rizvi F, Forestell B, Greer A, Hewitt M, Fernando SM, Mehta S, Eltorki M, Siemieniuk R, Duffett M, Bhatt M, Burry L, Perry JJ, Petrosoniak A, Pandharipande P, Welsford M, Rochwerg B. Pharmacological agents for procedural sedation and analgesia in the emergency department and intensive care unit: a systematic review and network meta-analysis of randomised trials. Br J Anaesth. 2024 Mar;132(3):491-506. doi: 10.1016/j.bja.2023.11.050. Epub 2024 Jan 6. PMID: 38185564.Smith, Heidi A. B. MD, MSCI (Chair)1,2; Besunder, James B. DO, FCCM3,4; Betters, Kristina A. MD1; Johnson, Peter N. PharmD, BCPS, BCPPS, FCCM, FPPA, FASHP5,6; Srinivasan, Vijay MBBS, MD, FCCM7,8; Stormorken, Anne MD9,10; Farrington, Elizabeth PharmD, FCCM11; Golianu, Brenda MD12,13; Godshall, Aaron J. MD14; Acinelli, Larkin CPNP-AC, ACHPN15; Almgren, Christina CPNP16; Bailey, Christine H. MD17; Boyd, Jenny M. MD18,19; Cisco, Michael J. MD20; Damian, Mihaela MD, MPH21,22; deAlmeida, Mary L. MD23,24; Fehr, James MD13,25; Fenton, Kimberly E. MD, FCCM14; Gilliland, Frances DNP, CPNP-AC/PC26,27; Grant, Mary Jo C. CPNP-AC, PhD, FAAN28; Howell, Joy MD29; Ruggles, Cassandra A. PharmD, BCCCP, BCPPS30; Simone, Shari DNP31,32; Su, Felice MD21,22; Sullivan, Janice E. MD33,34; Tegtmeyer, Ken MD, FAAP, FCCM35,36; Traube, Chani MD, FCCM29; Williams, Stacey CPNP-AC37; Berkenbosch, John W. MD, FAAP, FCCM (Chair)33,34. 2022 Society of Critical Care Medicine Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility. Pediatric Critical Care Medicine 23(2):p e74-e110, February 2022. | DOI: 10.1097/PCC.0000000000002873Benzoni T, Agarwal A, Cascella M. Procedural Sedation. [Updated 2025 Mar 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551685/Kerson AG, DeMaria R, Mauer E, Joyce C, Gerber LM, Greenwald BM, Silver G, Traube C. Validity of the Richmond Agitation-Sedation Scale (RASS) in critically ill children. J Intensive Care. 2016 Oct 26;4:65. doi: 10.1186/s40560-016-0189-5. PMID: 27800163; PMCID: PMC5080705.Tel-Dan SF, Shavit D, Nates R, Samuel N, Shavit I. Emergency Physician-Administered Sedation for Thoracostomy in Children With Pleuropneumonia. Pediatr Emerg Care. 2021 Dec 1;37(12):e1209-e1212. doi: 10.1097/PEC.0000000000001975. PMID: 31929389.Cosgrove P, Krauss BS, Cravero JP, Fleegler EW. Predictors of Laryngospasm During 276,832 Episodes of Pediatric Procedural Sedation. Ann Emerg Med. 2022 Dec;80(6):485-496. doi: 10.1016/j.annemergmed.2022.05.002. Epub 2022 Jun 23. PMID: 35752522.Cravero JP, Blike GT, Beach M, Gallagher SM, Hertzog JH, Havidich JE, Gelman B; Pediatric Sedation Research Consortium. Incidence and nature of adverse events during pediatric sedation/anesthesia for procedures outside the operating room: report from the Pediatric Sedation Research Consortium. Pediatrics. 2006 Sep;118(3):1087-96. doi: 10.1542/peds.2006-0313. PMID: 16951002.

You are not doing the heavy lifting alone anymore.If you are living with symptoms that seem confusing, inconsistent, or flat-out exhausting, we have a vital surprise for you. For years, the Lichen Sclerosus Support Network (LSSN) has been a dedicated sanctuary for the LS community. But we know that many of our brothers and sisters are also navigating the painful, isolating world of Lichen Planus (LP) without a clear place to call home. Today, that completely changes. LSSN is officially expanding our mission to build a dedicated resource home for Lichen Planus. Joining host Kathy to launch this new frontier is Dr. Erin Foster, a leading mucosal specialist from Oregon Health & Science University. Dr. Foster is stepping up as the head of our brand-new LP department to help turn scattered search spirals into hard clinical research, clearer tracking tools, and real community hope. Visit our new LP website at https://aboutlichenplanus.comWhat You Will Learn: Core Episode TakeawaysThe Blueprint of Lichen Planus: How this autoimmune response targets the deep T-cells of your body, and why it can show up across your skin, mouth, scalp, nails, esophagus, or genitals. The Diagnostic Blur (LS vs. LP): Why classic textbook definitions are outdated. Dr. Foster shares why hyperkeratotic LP can present as completely white patches on the vulva, mimicking lichen sclerosus perfectly and causing years of misdiagnosis. The 3-to-9 Month Medication Trigger Window: A look at how common everyday medications like Ibuprofen, Metformin, and Beta-blockers can set off a delayed immune flare-up months after your first dose. The Truth About Scarring: Why identifying symptoms early in areas like the scalp (LPP) or moist mucosal tissues is vital to halt irreversible tissue fusion and hair loss. The Systemic Escalation Ladder: A breakdown of how treatments look when topical steroid creams aren't enough, including safe pills like Hydroxychloroquine and immune modulators like Methotrexate. *Self-Advocacy & Educational Use Only. This podcast episode and its accompanying notes exist to organize personal observations, validate patient experiences, and support informed conversations with your care team. This content does not diagnose medical conditions, replace formal clinical examinations, or determine medication directives. LichenS Support Network does not provide clinical diagnoses or official treatment plans. Please coordinate directly with a qualified, licensed professional for all medical evaluations, physical tissue biopsies, and therapeutic care strategies.

In this episode of Inside the Lab, Patricia Delgado and Liz Etkin-Kramer explore the evolving landscape of cervical cancer screening amid recent guideline updates emphasizing primary HPV testing, self-collection, and revised screening exit criteria. The conversation examines the challenges posed by HPV-negative cervical cancers and highlights the importance of close collaboration between pathology and OB-GYN teams when screening results, clinical findings, and patient presentation do not align neatly. Through a detailed case discussion, the guests describe how ongoing communication and iterative review between specialties ultimately leads to improved diagnostic accuracy in difficult cases, underscoring the value of interdisciplinary partnership in complex gynecologic cases.Key TakeawaysRecent cervical cancer screening updates are not yet fully harmonized across major professional organizations, creating a transitional landscape that clinicians and laboratories must navigate carefully.HPV-negative cervical lesions and cancers can present significant diagnostic challenges, particularly when standard screening results do not match clinical suspicion.Strong, iterative collaboration between OB-GYNs and pathologists can be critical for resolving complex cases and achieving accurate diagnoses, as illustrated by the discussion of lobular endocervical glandular hyperplasia.

You're doing the work—the content, the media, the campaigns—and the minute leadership asks what it's all worth, you've got nothing to hand them. So you go looking for a better dashboard. In this week's Spin Sucks podcast episode, Gini Dietrich explains why a measurement problem is almost never a measurement problem—it's the first place a broken system shows up—and shares the Diagnostic data proving the biggest budgets aren't buying readiness. You'll learn why pitching the PESO Model® as a marketing expense loses the budget every time, and how to reframe it as the operating system that actually gets funded. Take the PESO Model® Diagnostic: https://spinsucks.com/self-peso-diagnostic/  PESO Model® Certification: https://spinsucks.com/peso-model-certification/

A guide to diagnosing, imaging, and managing acute renal colic and nephrolithiasis in the ED. Hosts: Brian Gilberti, MD Avir Mitra, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Nephrolithiasis.mp3 Download Leave a Comment Tags: Kidney Stones, Urology Show Notes 1. CLINICAL CORE & PHYSIOLOGIC FRAMEWORK Epidemiologic Risk Profiles Lifetime incidence parameters hover around 1 in 11, presenting with a prominent male sex skew. Peak demographic manifestation concentrated within the 30–60 age band. High-yield temporal parameter: 50% recurrence vector within a 5-year post-initial-insult window. Mineralogical Composition Vectors Calcium oxalate crystals represent the predominant structural matrix. Struvite configurations (magnesium ammonium phosphate matrix) account for 1–2% of cohorts. Struvite stones function explicitly as infection-driven configurations secondary to upper tract proliferation; higher distribution index noted in female cohorts. Etiological & Modifiable Relational Dynamics Profound systemic dehydration or low baseline fluid throughput states. High-sodium diet structures and heavy animal-protein consumption loads. Positive genetic/familial history variables. Relative risk modulation: Each variable independently operates to expand baseline risk by a factor of 2x to 3x. Pathophysiologic Symptom Complexes Acute, sudden-onset, maximum-intensity (10/10) unilateral flank pain. Classic structural radiation vector tracking downward toward the ipsilateral groin/genitourinary dermatomes. Distinctive behavioral marker: Renal colic pacing/writhing behavior with zero antalgic position availability. Concomitant autonomic triggers: Nausea and emesis manifest in 50% of acute presentations. Physical Exam Discordance Metrics Severe subjective distress contrasted with a characteristically soft, completely non-tender abdominal palpation exam. CVA tenderness is completely variable and lacks reliable negative predictive value. Atypical Presentation Classifications Vague, poorly localized abdominal pain presentations occurring in up to 20% of active cases. Isolated lower urinary tract irritative signs including acute frequency or severe urgency. Incidental & Asymptomatic Dynamics Silent intrarenal or ureteral stones found incidentally. Longitudinal tracking demonstrates up to 33.3% of initially asymptomatic cohorts convert to fully symptomatic renal colic within a multi-year tracking window. 2. EXCLUSION DIAGNOSES & CRITICAL PATHWAY RED FLAGS Vascular Mimics: AAA rupture/expansion. This is a mandatory exclusion pathway in elderly cohorts presenting with acute flank or back pain. Physical tracking requires active exploration for an expansile, pulsatile abdominal mass. Gynecologic Emergencies: Ruptured ectopic pregnancy. Demands universal screening protocols via rapid beta-hCG testing in all female patients of childbearing potential presenting with lower abdominal/pelvic localization. Infectious Upper Tract Decompensation: Acute uncomplicated pyelonephritis. Differentiated via persistent high spikes, high fevers, systemic shaking chills, and profound pyuria. Genitourinary Structural Crises: Acute testicular torsion. Mandates a thorough, explicit scrotal/testicular structural exam if the flank pain radiates into the scrotum. Gastrointestinal and Adnexal Torsional Confounds: Acute appendicitis variants, acute mesenteric/bowel ischemia, and ovarian torsion syndromes. 3. LABORATORY TESTING & PHYSIOLOGIC EVALUATION Urinalysis Interpretation Nuances Microscopic or gross hematuria presents in approximately 66% to 90% of acute cases. Critical Pathological Caveat: Complete absence of hematuria documented in 20% to 33.3% of confirmed, acute obstructing ureteral stones. Diagnostic rule: A pristine urinalysis with zero red blood cells is entirely insufficient to exclude acute ureterolithiasis. Urinary pH as a Composition Clue Consistently low urinary pH parameters (pH < 5.5) point strongly toward a uric acid crystalline composition. Elevated urinary pH parameters (pH > 7.5) indicate the presence of urease-producing microbial pathogens, pointing toward a struvite infection stone. Infectious Screening Metrics Active tracking for marked pyuria, positive leukocyte esterase, and bacterial nitrites to rule out an obstructed, infected upper urinary tract system. BMP Immediate quantification of baseline serum creatinine to establish accurate eGFR values. Targeting detection of post-renal AKI from bilateral obstruction, unilateral obstruction in a single functioning kidney, or severe volume depletion. CBC Evaluation for marked leukocytosis. Physiologic Nuance: Mild-to-moderate white blood cell count elevations frequently represent non-specific stress demargination driven by severe pain and repetitive vomiting. High-grade white blood cell shifts demand immediate exclusion of systemic bacteremia or an infected, obstructed urinary system. Adjunctive Lab Pathways Rapid qualitative urine hCG testing. Reflex urine culture execution whenever urinalysis metrics display significant inflammatory profiles or clinical suspicion of UTI is high. 4. IMAGING MODALITIES & ALGORITHMIC CLINICAL SELECTION Non-Contrast CT Diagnostics Gold standard; diagnostic sensitivity and specificity parameters exceed 95% for stones >2 mm. Provides precise quantification of stone diameter (mm), exact localization (proximal, mid, or distal ureter), and degree of secondary hydronephrosis. Excellent structural visualization for detecting or ruling out alternate retroperitoneal, vascular, or intra-abdominal pathologies. Contrast-Enhanced CT Protocols Indicated when alternative intra-abdominal surgical pathology is highly suspected over isolated renal colic. Retains diagnostic capability to identify urinary tract stones >3 mm even within contrast-enhanced phases. NCCT Structural Architecture Limitations Standard stone protocol CT scans are executed in a prone position without IV contrast enhancement. It does not opacify the ureteral lumen. Presents a cumulative radiation exposure penalty when utilized serially across recurrent ED presentations. POCUS / Radiology Ultrasound Direct stone visualization capabilities are modest, operating at approximately 50% to 60% sensitivity, and is highly dependent on anatomical positioning at the extreme proximal ureter or the UVJ. Secondary obstruction tracking: Demonstration of hydronephrosis operates at a high sensitivity of approximately 80%. POCUS Clinical Utility Metrics Eliminates ionizing radiation exposure and allows immediate, rapid real-time execution directly at the patient’s bedside. Confirmation of significant hydronephrosis within a classic clinical presentation yields high post-test probability for stone presence while lowering suspicion for vascular catastrophes like a AAA. KUB Radiography Extremely poor overall diagnostic sensitivity, hovering around 57%. Fails to image radiolucent configurations (pure uric acid matrices) or small stones measuring

This week on the show I share a case study on a 2016 Kia Optima 2.4L that's setting a P0010 in the ECM after multiple components have been replaced, including the ECM. This is a common code for these vehicles and they have multiple failure points in this system. This car turned out to be something more interesting than the typical fault. Website- https://autodiagpodcast.com/Facebook Group- https://www.facebook.com/groups/223994012068320/YouTube- https://www.youtube.com/@automotivediagnosticpodcas8832Email- STmobilediag@gmail.comPlease make sure to check out our sponsors!SJ Auto Solutions- https://sjautosolutions.com/Automotive Seminars- https://automotiveseminars.com/L1 Automotive Training- https://www.l1training.com/Autorescue tools- https://autorescuetools.com/  

If you've ever felt like you're doing all the right things and still running on empty — this episode is going to explain exactly why.And more importantly, it's going to show you where to actually focus first.This episode is the full audio from The Capacity Audit — a live workshop I hosted this week on Zoom.We did something I've never done publicly before: a live, 25-question nervous system diagnostic across five capacity categories, followed by a deep dive into the highest-leverage move for each category.Grab a pen. You can take the audit yourself as you listen and walk away knowing your lowest capacity category and your single most impactful next step.Here's what makes this one different from every other nervous system episode you've heard: we're not talking about what to do.We're talking about where to start — because for most high-achieving women, the problem isn't information. It's that they've been solving a nervous system problem with productivity solutions. This episode changes that.What you'll learn:How to score yourself across five capacity categories: Emotional, Physical & Energetic, Stress, Relational, and Joy & PleasureWhat your scores actually mean — and how to identify your single highest-leverage entry pointThe 80/20 that changes everything: why your body is 4x more influential than your mind, and why everything you've tried has only worked partiallyThe difference between state shifters and trait shifters — and why you need both to actually expand your capacity--Join The Capacity Method (we start June 15th!) -> Check it out HERE--

We're surrounded by plastics and environmental chemicals every day, but only recently have scientists begun to understand how deeply they may be affecting human health. On this episode of The Dr. Hyman Show, I sit down with Dr. Shanna Swan to explore what the latest science reveals about plastics, fertility, hormone health, and the everyday habits that may be shaping our biology more than we realize. Watch the full conversation on YouTube, or listen wherever you get your podcasts. We Examine: • Why scientists are increasingly concerned about declining sperm counts, fertility, and hormone health • What microplastics, phthalates, BPA, and PFAS actually do inside your body • Why heating food in plastic can dramatically increase exposure to endocrine-disrupting chemicals • The practical changes that may help you reduce exposure and support long-term health This conversation isn't about fear, rather it's about understanding how everyday exposures shape our health and where small, practical changes can make a meaningful difference. If this episode has left you thinking differently about everyday exposure and you want to learn more, here are a few great places to start: • Watch The Plastic Detox • Explore Dr. Swan's work through the Action Science Initiative • Visit UnplasticYourLife.com for practical ways to reduce exposure at home View Show Notes From This Episode Get Free Weekly Health Tips from Dr. Hyman https://drhyman.com/pages/picks?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Sign Up for Dr. Hyman's Weekly Longevity Journal https://drhyman.com/pages/longevity?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Join the 10-Day Detox to Reset Your Health https://drhyman.com/pages/10-day-detox Join the Hyman Hive for Expert Support and Real Resultshttps://drhyman.com/pages/hyman-hive This episode is brought to you by Seed, Big Bold Health, Timeline, BON CHARGE, Sulighten and BIOptimizers. Go to seed.com/hyman and use code 20HYMAN to get 20% off your first month. Go to bigboldhealth.com/drhyman and use code HYMAN15 to save 15% on your first order. Visit timeline.com/drhyman for 20% off a subscription on top of new starting price of $79. Head to bioptimizers.com/hyman and use promo code HYMAN at checkout to save 15%. Head to fatty15.com/HYMAN today and use code HYMAN for 15% off your 90-day subscription Starter Kit. (0:00) Microplastics in the human body and their sources (0:56) Introduction to Dr. Shanna Swan (3:34) The Plastic Detox documentary and endocrine disruptors (5:21) Dr. Swan's research journey and phthalates (6:29) Decline in sperm count and reproductive impacts (8:45) Early research and phthalate syndrome in humans (11:03) Sources and broader impact of endocrine-disrupting chemicals (19:38) Classes of hormone-altering chemicals and health impacts (22:51) Health impacts beyond reproduction (24:20) Personal and clinical experiences with microplastics (27:02) Measuring microplastics and routes of human exposure (29:29) Methods to reduce microplastic exposure (31:14) Biological and regulatory aspects of microplastics (35:02) Plastic Detox movie findings and intervention results (41:16) Chemicals in microplastics and their effects (47:21) Legislation and consumer protection against toxic chemicals (50:54) Diagnostic testing for toxic exposure: importance and costs (53:09) Practical steps to reduce chemical exposures (55:35) Avoiding plastic and toxic exposures in daily life (58:10) Skincare, fragrance, and chemical exposure (1:01:19) Rapid-fire questions on health and environmental practices (1:09:06) Resources for testing and exposure reduction